SyVento BioTech is excited to announce our participation in the prestigious Pharma Partnering Summit taking place in Basel, Switzerland, from May 22nd to 23rd, 2024, at the Mövenpick Hotel. Our esteemed representatives, Eliza Milewicz, Member of the Supervisory Board, and Tomasz Piec, Chairman of the Supervisory Board, will be actively engaged in this premier event.

The Pharma Partnering Summit serves as a critical platform for forging valuable connections and fostering collaboration within the life sciences industry. It brings together senior executives and dealmakers from leading companies, fostering partnerships across various stages of development.

Key Areas of Focus for SyVento at the Summit:

  • Expanding our Network: We will actively engage with industry leaders, building strong relationships that can lead to future collaborations.
  • Identifying Strategic Partners: Exploring opportunities to partner with companies that complement our expertise and accelerate the development of innovative mRNA therapeutics.
  • Unlocking Funding Potential: Connecting with potential investors and collaborators to support the advancement of our pipeline and vision.
  • Knowledge Sharing: Engaging in discussions led by industry experts to gain valuable insights into best practices for successful partnerships.

By participating in the Pharma Partnering Summit, SyVento BioTech seeks to drive innovation, foster collaborations that combine expertise and resources to accelerate progress in mRNA therapeutics, and shape the future of life sciences by contributing to the advancement of life-changing treatments.

Follow us on X and LinkedIn for more updated content!